Bio-Key International Inc (NASDAQ:BKYI) does about 2.28M shares in volume on a normal day but saw 4303843 shares change hands in the recent trading day. The company now has a market cap of 4.69M USD. Its current market price is $1.50, marking an increase of 4.17% compared to the previous close of $1.44. The 52 week high reached by this stock is $3.22 whilst the lowest price level in 52 weeks is $0.52.
Bio-Key International Inc (BKYI) has a 20-day trading average at $1.2696 and the current price is -53.41% off the 52-week high compared with 189.18% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.1451 and its 200-day simple moving average is $1.3937. If we look at the stock’s price movements over the week, volatility stands at 23.37%, which decreases to 20.18% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 54.49 to suggest the stock is neutral.
The consensus objective for the share price is $3.00, suggesting that the stock has a potential upside of 50.0% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 26, 2021 when Maxim Group upgraded the stock to “Buy” and issued a price target of $6.
The current price level is 18.15%, 30.99%, and 7.62% away from its SMA20, SMA50, and SMA200 respectively, with the BKYI price moving below the 50-day SMA on current market day. Bio-Key International Inc (BKYI) stock is up 7.91% over the week and 36.36% over the past month. Its price is -12.28% year-to-date and -31.51% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.35 and -1.86 for whole year. Expected sales for next quarter are $2.5M, which analysts say will come at $7.75M for the current fiscal year and next year at $8.5M. In addition, estimates put the company’s current quarterly revenue at an average of $2.29M.
To reach the target analysts have set, the stock logically needs to grow 50.0 percent from here.
Outstanding shares total 3.11M with insiders holding 5.57% of the shares and institutional holders owning 9.26% of the company’s common stock. The company has a return on investment of -3416.48% and return on equity of -527.28%. The beta has a value of 0.00. Price to book ratio is 35.05 and price to sales ratio is 0.73.
